References
- Ackers R, Murray ML, Besag FMC, Wong ICK. (2007). Prioritizing children’s medicines for research: a pharmacoepidemiological study of antiepileptic drugs. Br J Clin Pharmacol 63: 689–97.
- Armutcu F, Ozerol E, Gurel A, Kanter M, Vural H, Yakinci C., Akyol O. (2004). Effect of long-term therapy with sodium valproate on nail and serum trace element status in epileptic children. Biol Trace Elem Res 102(1–3):1–10.
- Ashraf W, Jaffar M, Mohammed D, Iqbal J. (1995) Utilization of scalp hair for evaluating epilepsy in male and female groups of the Pakistan population. Sci Total Environ 164: 69–73.
- Ashrafi MR, Shabanian R, Abbaskhanian A, Nasirian A, Ghofrani M, Mohammadi M, Zamani GR, Kayhanidoost Z, Ebrahimi S, Pourpak Z. (2007). Selenium and intractable epilepsy: is there any correlation? Pediatr Neurol 36: 25–9.
- Ben‐Menachem E. (2007). Weight issues for people with epilepsy—a review. Epilepsia 48: 42–45.
- Camfield P, Camfield C. (2015). Incidence, prevalence and aetiology of seizures and epilepsy in children. Epileptic Disorders 17(2): 117–123.
- Castilla-Guerra L, del Carmen Fernández-Moreno M, López-Chozas JM, Fernández-Bolaños R. (2006). Electrolytes disturbances and seizures. Epilepsia 47: 1990–8.
- Cohen-Solal M. (2002). Strontium overload and toxicity: impact on renal osteodystrophy. Nephrol Dial Transplant 17(2): 30–4.
- Cornelis R, Heinzow B, Herber RF, Christensen JM, Poulsen OM, Sabbioni E, Templeton DM, Thomassen Y, Vahter M, Vesterberg O. (1996). Sample collection guidelines for trace elements in blood and urine. IUPAC Commission of Toxicology. J Trace Elem Med Biol 10: 103–27.
- De Bittencourt PR, Adamolekum B, Bharucha N, Carpio A, Cossío OH, Danesi MA, Dumas M, Meinardi H,Ordinario A, Senanayake N, Shakir R, Sotelo J. (1996). Epilepsy in the tropics: I. Epidemiology, socioeconomic risk factors, and etiology. Epilepsia 37: 1121–7.
- Doneray H, Kara IS, Karakoc A, Tan H, Orbak Z. (2012). Serum thyroid hormone profile and trace elements in children receiving valproic acid therapy: A longitudinal and controlled study. J Trace Elem Med Biol 26: 243–7. Dudek FE. (2001). Zinc and Epileptogenesis. Epilepsy Curr 1: 66–70.
- Frederickson CJ, Suh SW, Silva D, Frederickson CJ, Thompson RB. (2000). Importance of zinc in the central nervous system: the zinc-containing neuron. J Nutr 130(5S): 1471S–83S.
- Gelisse P, Juntas‐Morales R, Genton P, Hillaire‐Buys D, Diaz O, Coubes P, Crespel A. (2008). Dramatic weight loss with levetiracetam. Epilepsia 49: 308–315.
- Hamed SA, Abdellah MM, El-Melegy N (2004). Blood levels of trace elements, electrolytes, and oxidative stress/antioxidant systems in epileptic patients. J Pharmacol Sci 96: 465–73.
- Hunt DM. (1980). Copper and neurological function. Ciba Found Symp 79: 247–66.
- Hurd RW, Van Rinsvelt HA, Wilder BJ, Karas B, Maenhaut W, De Reu L. (1984). Selenium, zinc, and copper changes with valproic acid: possible relation to drug side effects. Neurology 34: 1393–5.
- Hurd RW, Wilder BJ, Street JJ, Sciscent BL. (1981). Zinc binding by valproic acid. Neuroscience Abstr 7: 813.
- Ikeda M. (2001). Iron overload without the C282Y mutation in patients with epilepsy. J Neurol Neurosurg Psychiatr 70: 551–3.
- Indian Epilepsy Society. 2008. Guidelines for Management of Epilepsy in India (GEMIND). [accessed on 23 Jul 2017] Available from: http://www.ilae.org/visitors/centre/guidelines.cfm
- Kaji M, Ito M, Okuno T, Momoi T, Sasaki H, Yamanaka C, Yorifuji T, Mikawa H. (1992). Serum copper and zinc levels in epileptic children with valproate treatment. Epilepsia 33: 555–7.
- Keen CL, Peters JM, Hurley LS. (1989). The effect of valproic acid on 65Zn distribution in the pregnant rat. J Nutr 119: 607–11.
- Kürekçi AE, Alpay F, Tanindi S, Gökçay E, Ozcan O, Akin R, Işimer A, Sayal A. (1995). Plasma trace element, plasma glutathione peroxidase, and superoxide dismutase levels in epileptic children receiving antiepileptic drug therapy. Epilepsia 36: 600–4.
- Kuzuya T, Amioka K, Nabeshima T. (2002). Valproic acid increases biliary copper excretion in the rat. Epilepsy Res 51: 279–85.
- Kuzuya T, Hasegawa T, Shimizu K, Nabeshima T. (1993). Effect of anti-epileptic drugs on serum zinc and copper concentrations in epileptic patients. Int J Clin Pharmacol Ther Toxicol 31: 61–5.
- Kwong KL, Tsui KW, Wu SP, Yung A, Yau E, Eva F, Ma KC, Cherk S, Liu KT, Cheng WW, Yau MM. (2012). Utilization of antiepileptic drugs in Hong Kong children. Pediatr Neurol 46: 281–6.
- Lerman-Sagie T, Statter M, Szabo G, Lerman P. (1987). Effect of valproic acid therapy on zinc metabolism in children with primary epilepsy. Clin Neuropharmacol 10: 80–6.
- Morohashi T, Sano T, Yamada S. (1994). Effects of strontium on calcium metabolism in rats. I. A distinction between the pharmacological and toxic doses. Jpn J Pharmacol 64: 155–62.
- Nazıroğlu M, Yürekli VA. (2013). Effects of antiepileptic drugs on antioxidant and oxidant molecular pathways: focus on trace elements. Cell Mol Neurobiol 33: 589–99.
- Nicholas JM, Ridsdale L, Richardson MP, Ashworth M, Gulliford MC. (2012). Trends in antiepileptic drug utilisation in UK primary care 1993–2008: Cohort study using the General Practice Research Database. Seizure 21: 466–70.
- Oste L, Bervoets AR, Behets GJ, Dams G, Marijnissen RL, Geryl H, Lamberts LV, Verberckmoes SC, Van Hoof VO, De Broe ME, D’Haese PC. (2005). Time-evolution and reversibility of strontium-induced osteomalacia in chronic renal failure rats. Kidney Int 67: 920–30.
- Pack AM, Gidal B, Vazquez B. (2004). Bone disease associated with antiepileptic drugs. Cleve Clin J Med 71(2): S42–48.
- Palm R, Hallmans G, Wahlström G. (1986). Effects of long-term phenytoin treatment on brain weight and zinc and copper metabolism in rats. Neurochem Pathol 5: 87–106.
- Patsalos PN. (2000). Pharmacokinetic profile of levetiracetam: toward ideal characteristics. Pharmacol Ther 85: 77–85.
- Peter RC, Carol S. (2006). Camfield, pediatric epilepsy: An overview, in : Pediatric Neurology principles and practice (Swaiman KF) pp. 981-989, Mosby, 4 th edition.
- Robert E, Löfkvist E, Mauguiere F. (1984). Valproate and spina bifida. Lancet 2: 1392.
- Roy MK, Das D. (2013). Indian Guidelines on Epilepsy. Chapter 116. Section 16: Neurology. Medicine Update, 2013. The Association of Physicians of India. [accessed 21 Jul 2017]. Available from: http://www.apiindia.org/medicine_update_2013/chap116.pdf.
- Saad K, Hammad E, Hassan AF, Badry R. (2014). Trace element, oxidant, and antioxidant enzyme values in blood of children with refractory epilepsy. Int J Neurosci 124: 181–6.
- Sarangi SC, Tripathi M, Kakkar AK, Gupta YK. (2014). Effect of antiepileptic therapy on trace elements status in Indian population in a tertiary care hospital from northern India: A cross sectional study. Epilepsy Res 108: 917–27.
- Sarangi SC, Tripathi M, Kakkar AK, Gupta YK. (2016). Comparison of body composition in persons with epilepsy on conventional & new antiepileptic drugs. Indian J Med Res 143(3): 323–30.
- Savaskan NE, Bräuer AU, Kühbacher M, Eyüpoglu IY, Kyriakopoulos A, Ninnemann O, Behne D, Nitsch R. (2003). Selenium deficiency increases susceptibility to glutamate-induced excitotoxicity. FASEB J 17: 112–4.
- Seven M, Basaran SY, Cengiz M, Unal S, Yuksel A. (2013). Deficiency of selenium and zinc as a causative factor for idiopathic intractable epilepsy. Epilepsy Res. 104: 35–9.
- Smith WG, Bone I. (1982). Copper, zinc and magnesium plasma levels in epilepsy. J Neurol Neurosurg Psychiatr 45: 1072.
- Steidl L, Tolde I, Svomová V. (1987). Metabolism of magnesium and zinc in patients treated with antiepileptic drugs and with magnesium lactate. Magnesium 6: 284–95.
- Suzuki T, Koizumi J, Moroji T, Shiraishi H, Hori T, Baba A, Kawai N, Tada K. (1992). Effects of long-term anticonvulsant therapy on copper, zinc, and magnesium in hair and serum of epileptics. Biol Psychiatry 31: 571–81.
- Tekin D, Taşdemir HA, Saraymen R. (2008). The effects of antiepileptic drugs on serum and hair trace element levels. Ankara Üniversitesi Tıp Fakültesi Mecmuası. 61(2).
- Tutor JC, Fernandez MP, Paz JM. (1982). Serum copper concentration and hepatic enzyme induction during long-term therapy with anticonvulsants. Clinical Chemistry 28: 1367–70.
- Tutor-Crespo MJ, Hermida J, Tutor JC (2003). Assessment of copper status in epileptic patients treated with anticonvulsant drugs by measuring the specific oxidase activity of ceruloplasmin. Epilepsy Res 56: 147–53.
- Verrotti A, Basciani F, Trotta D, Pomilio MP, Morgese G, Chiarelli F (2002). Serum copper, zinc, selenium, glutathione peroxidase and superoxide dismutase levels in epileptic children before and after 1 year of sodium valproate and carbamazepine therapy. Epilepsy Res 48: 71–5.
- Wojciak RW, Mojs E, Stanislawska-Kubiak M, Samborski W. (2013). The serum zinc, copper, iron, and chromium concentrations in epileptic children. Epilepsy Res 104: 40–4.
- Yilmaz Y, Tasdemir HA, Paksu MS. (2009). The influence of valproic acid treatment on hair and serum zinc levels and serum biotinidase activity. Eur J Paediatr Neurol 13: 439–43.
- Yuen WC, Whiteoak R, Thompson RP. (1988). Zinc concentrations in leucocytes of patients receiving antiepileptic drugs. J Clin Pathol 41: 553–5.